A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer.

Mutter R, Lu B, Carbone DP, Csiki I, Moretti L, Johnson DH, Morrow JD, Sandler AB, Shyr Y, Ye F, Choy H
Clin Cancer Res. 2009 15 (6): 2158-65

PMID: 19276291 · DOI:10.1158/1078-0432.CCR-08-0629

MeSH Terms (18)

Aged Antineoplastic Combined Chemotherapy Protocols Carboplatin Carcinoma, Non-Small-Cell Lung Celecoxib Combined Modality Therapy Cyclooxygenase 2 Inhibitors Female Humans Lung Neoplasms Male Middle Aged Neoplasm Staging Paclitaxel Prostaglandins Pyrazoles Sulfonamides Vascular Endothelial Growth Factor A

Connections (1)

This publication is referenced by other Labnodes entities: